INR Calculator - Free Online Tool

Convert prothrombin time (PT) to INR — with clinical interpretation, dose guidance, and trend tracking

The International Normalized Ratio (INR) is the world's standard measurement for monitoring anticoagulation therapy — specifically warfarin (Coumadin) — in patients at risk for blood clots. Our free INR Calculator converts your raw prothrombin time (PT) lab result into the standardized INR value used by clinicians worldwide, and provides a comprehensive set of clinical tools to help you understand what your result means. The INR system was developed by the World Health Organization specifically to solve a critical problem in anticoagulation medicine: different laboratories used different thromboplastin reagents to perform the PT test, resulting in incompatible values from one lab to another. A patient's PT of 20 seconds at one hospital might represent very different anticoagulation than a PT of 20 seconds at a different facility. INR standardizes this by accounting for the sensitivity of each laboratory's specific reagent — a value called the International Sensitivity Index (ISI) — ensuring consistent, comparable results regardless of where the test is performed. Understanding your INR is essential if you take warfarin (brand names Coumadin or Jantoven). Warfarin is a powerful anticoagulant prescribed for conditions including atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE), and patients with mechanical heart valves. These conditions all carry risk of dangerous blood clot formation, and warfarin reduces that risk by slowing the clotting cascade. However, the therapeutic window for warfarin is narrow — too little anticoagulation leaves you at risk for clots, while too much creates unacceptable bleeding risk. For most warfarin indications — including atrial fibrillation, DVT, pulmonary embolism, and tissue heart valves — the target INR range is 2.0 to 3.0. Patients with mechanical prosthetic heart valves typically require a higher target of 2.5 to 3.5, because clot formation on a mechanical valve can be immediately life-threatening. Some newer valve designs, such as the On-X mechanical aortic valve, allow a reduced target of 1.5 to 2.0 after three months when combined with aspirin therapy. Our INR Calculator implements the standard formula: INR = (Patient PT / Normal PT) raised to the power of ISI. The patient PT is your measured prothrombin time in seconds. The normal PT (also called control PT or mean normal PT) is the geometric mean PT for a group of healthy, non-anticoagulated individuals tested in the same laboratory using the same reagent. The ISI is a calibration value assigned by the thromboplastin manufacturer that reflects how sensitive the reagent is compared to the WHO reference standard — modern recombinant thromboplastins typically have ISI values between 0.94 and 1.4. Beyond the basic calculation, this tool provides a complete clinical support package. The INR gauge visualization shows where your result falls across the full spectrum from normal to critical. The therapeutic range selector checks whether your INR is within the target range for your specific clinical indication. The warfarin dose adjustment tool calculates a suggested weekly dose change based on ACCP and ASH anticoagulation guidelines. The INR trend tracker lets you enter up to five historical readings to visualize your INR pattern over time. A collapsible panel lists medications and dietary factors that commonly affect INR results. This calculator is designed for warfarin patients monitoring their anticoagulation, healthcare providers needing a quick reference tool, and anyone seeking to understand their INR result better. All calculations run entirely in your browser — no data is stored or transmitted anywhere. Always discuss your INR results with your healthcare provider before making any changes to your warfarin dose.

Understanding INR and Prothrombin Time

INR (International Normalized Ratio) is the standardized measure of how long it takes your blood to clot, specifically used to monitor warfarin anticoagulation therapy and screen for coagulation disorders.

What Is Prothrombin Time (PT)?

Prothrombin time (PT) measures how quickly your blood clots through the extrinsic and common coagulation pathways. The test involves adding a tissue factor reagent (thromboplastin) and calcium to a plasma sample and measuring how long it takes for a clot to form. A normal PT is approximately 9.8 to 12.7 seconds in most laboratories. PT is prolonged when clotting factors are deficient or inhibited — which is exactly what warfarin does by blocking vitamin K-dependent clotting factor synthesis (factors II, VII, IX, X, and proteins C and S). PT is most sensitive to factor VII deficiency, which is why it responds quickly to warfarin initiation and changes.

The INR Formula and ISI

INR is calculated as: INR = (Patient PT / Normal PT) raised to the power of ISI. The International Sensitivity Index (ISI) is a calibration value specific to each laboratory's thromboplastin reagent. It reflects how sensitive that reagent is compared to the WHO International Reference Preparation. Modern recombinant thromboplastins typically have ISI values between 0.94 and 1.4 — the closer to 1.0, the more sensitive the reagent and the smaller the variation in INR across laboratories. Older rabbit-brain thromboplastins had ISI values of 1.4 to 3.0, which caused much larger INR variation. This is why the same patient tested at two labs using different reagents should now get very similar INR values, even if their raw PT seconds differ substantially.

INR Therapeutic Ranges

The appropriate INR range depends on your clinical indication. For most warfarin patients — those with atrial fibrillation, DVT, pulmonary embolism, tissue heart valves, or valvular heart disease — the standard target is 2.0 to 3.0. Patients with mechanical prosthetic heart valves require a higher target of 2.5 to 3.5 due to the greater thromboembolism risk associated with these devices. The On-X mechanical aortic valve is an exception: after three months of therapeutic anticoagulation combined with aspirin, guidelines allow reduction to a target of 1.5 to 2.0. An INR below your target range (subtherapeutic) means you may not have adequate clot protection, while an INR above your target (supratherapeutic) increases your bleeding risk.

Limitations and Important Caveats

INR was specifically designed for monitoring vitamin K antagonist (VKA) therapy such as warfarin, and the WHO explicitly cautions against using INR to assess coagulation in patients not on VKA therapy. In liver disease, for example, INR does not accurately reflect bleeding risk because liver disease affects multiple pro- and anti-coagulant factors simultaneously, not just the vitamin K-dependent pathway. Direct oral anticoagulants (DOACs) such as rivaroxaban, apixaban, and dabigatran do not require INR monitoring — they are dosed at fixed amounts. INR results can also be affected by lupus anticoagulant, very high or low hematocrit, direct thrombin inhibitors, and collection technique issues. Always confirm suspicious or unexpected INR results with repeat testing before acting on them clinically.

INR Calculation Formulas

INR Formula

INR = (Patient PT / Mean Normal PT) ^ ISI

The WHO-standardized formula for converting prothrombin time to INR. The patient's PT is divided by the laboratory's mean normal PT, then raised to the power of the ISI (International Sensitivity Index) specific to the thromboplastin reagent used.

PT Ratio

PT Ratio = Patient PT / Mean Normal PT

The intermediate step in the INR calculation. The PT ratio alone does not account for reagent sensitivity differences between laboratories, which is why the ISI exponent is applied to produce the standardized INR.

Warfarin Dose Adjustment (Percentage Method)

New Weekly Dose = Current Weekly Dose × (1 ± Adjustment %)

Dose adjustment guidelines suggest increasing or decreasing the total weekly warfarin dose by 5–20% depending on how far the INR falls outside the target range. Small adjustments (5–10%) for minor deviations, larger adjustments (10–20%) for significant out-of-range values.

INR Reference Tables

Target INR Ranges by Clinical Indication

Recommended therapeutic INR ranges from ACCP, AHA/ACC, and ESC guidelines for various clinical indications requiring warfarin anticoagulation.

Clinical Indication	Target INR	Range
Atrial Fibrillation (AF)	2.5	2.0–3.0
Deep Vein Thrombosis (DVT)	2.5	2.0–3.0
Pulmonary Embolism (PE)	2.5	2.0–3.0
Tissue (Bioprosthetic) Heart Valve	2.5	2.0–3.0
Antiphospholipid Syndrome	2.5	2.0–3.0
Mechanical Aortic Valve (bileaflet, low risk)	2.5	2.0–3.0
Mechanical Mitral/Tricuspid Valve	3.0	2.5–3.5
Mechanical Aortic Valve + Risk Factors	3.0	2.5–3.5
Recurrent Systemic Thromboembolism	3.0	2.5–3.5
On-X Mechanical Aortic (after 3 mo + ASA)	1.75	1.5–2.0

Warfarin Dose Adjustment Guide by INR

General dose adjustment recommendations based on current INR relative to a standard target range of 2.0–3.0. Always confirm with your healthcare provider before changing doses.

Current INR	Action	Dose Change	Recheck
< 1.5	Increase dose + consider booster	+10–20%	3–7 days
1.5–1.9	Increase dose	+5–15%	3–7 days
2.0–3.0	Continue current dose	No change	4 weeks
3.1–3.9	Decrease dose or hold 1 dose	−5–15%	3–7 days
4.0–5.0	Hold 1–2 doses, then decrease	−5–20%	Next day
5.0–9.0	Hold warfarin, consider vitamin K	Contact provider	Same day
> 9.0	Hold warfarin, give vitamin K 2.5–5 mg	Emergency	Immediate

Worked Examples

Calculate INR from PT 18.5s with Mean Normal PT 12s and ISI 1.2

A patient on warfarin for atrial fibrillation has a PT of 18.5 seconds. The laboratory's mean normal PT is 12.0 seconds and the thromboplastin ISI is 1.2.

Calculate PT Ratio: 18.5 / 12.0 = 1.542

Apply ISI exponent: INR = 1.542 ^ 1.2

Calculate: 1.542 ^ 1.2 = e^(1.2 × ln(1.542)) = e^(1.2 × 0.4336) = e^0.5203 = 1.683

INR = 1.68 (rounded to two decimal places)

INR = 1.68. For an AF patient with a target range of 2.0–3.0, this INR is subtherapeutic. The patient does not have adequate anticoagulation and is at increased risk for stroke. A dose increase of 5–15% is recommended with recheck in 3–7 days.

Dose Adjustment for INR 3.8 on 35 mg/week Warfarin

A patient with DVT takes warfarin 5 mg daily (35 mg/week). Their INR is 3.8, above the target of 2.0–3.0. Determine the dose adjustment.

Current INR 3.8 is supratherapeutic (target 2.0–3.0)

Guidelines suggest holding 1 dose and decreasing by 5–15%

Apply 10% reduction: 35 mg/week × 0.90 = 31.5 mg/week

New daily dose: 31.5 / 7 = 4.5 mg/day

Hold one day's dose, then reduce to approximately 4.5 mg/day (31.5 mg/week). Recheck INR in 3–7 days. If no active bleeding, monitor closely. If any bleeding symptoms occur, seek immediate medical attention.

How to Use the INR Calculator

Locate Your Lab Report Values

Find your prothrombin time (PT) result on your lab report — it will be listed in seconds. You also need the normal PT (sometimes called control PT or mean normal PT), which is the reference value for healthy patients at your specific laboratory. Finally, locate the ISI (International Sensitivity Index) for the reagent used — this is usually printed on your lab report or available from your lab, and is typically between 0.9 and 1.7 for modern reagents.

Enter Values and Select Your Indication

Enter your patient PT, normal PT, and ISI into the three input fields. Optionally, select your clinical indication from the dropdown (e.g., atrial fibrillation, DVT, mechanical heart valve) to have the calculator automatically check whether your INR falls within the recommended therapeutic range for your specific condition. The INR calculates automatically as you type.

Review Your INR, Status, and Clinical Guidance

The results panel shows your calculated INR value, PT ratio, and interpretation status (Normal, Subtherapeutic, Therapeutic, Supratherapeutic, Critical, etc.). The INR zone gauge gives a visual overview of where you fall on the spectrum. The clinical guidance section shows a recommended dose action, bleeding risk level, and suggested recheck timing based on evidence-based anticoagulation guidelines.

Use the Advanced Tools

Expand the Warfarin Dose Adjustment Calculator by entering your current weekly dose to get a suggested new weekly dose. Use the INR Trend Tracker to enter previous readings and see whether your INR is trending up, down, or stable. Click the Factors panel to review which medications and foods may be affecting your INR. Export your result to CSV or print it for your medical appointment.

Frequently Asked Questions

What is a normal INR value?

For a healthy adult not taking any anticoagulation medication, a normal INR is 0.8 to 1.2. This corresponds to a normal prothrombin time of approximately 9.8 to 12.7 seconds in most laboratories. An INR below 0.8 is unusually low and may suggest a hypercoagulable state, though this is rarely clinically significant in otherwise healthy individuals. An INR above 1.2 in a non-anticoagulated patient warrants further investigation for potential coagulation factor deficiencies, liver disease, vitamin K deficiency, or other conditions affecting the clotting cascade. If you are taking warfarin, your target INR will be higher than normal — typically 2.0 to 3.0 — and an INR of 1.0 to 1.5 would actually be considered subtherapeutic for your condition.

What is the target INR for warfarin therapy?

The target INR for most warfarin indications is 2.0 to 3.0. This range applies to atrial fibrillation, deep vein thrombosis, pulmonary embolism, tissue (bioprosthetic) heart valves (usually only for the first 3 months after surgery), valvular heart disease, and antiphospholipid syndrome. Patients with mechanical prosthetic heart valves generally require a higher target of 2.5 to 3.5 because the risk of clot formation on metal valve surfaces is greater. An exception is the On-X mechanical aortic valve: after an initial therapeutic period of 3 months combined with daily aspirin, guidelines allow a reduced target of 1.5 to 2.0. Catheter-related venous thrombosis prevention uses a low-intensity target of 1.2 to 1.5. Your physician will specify your individual target based on your condition and risk factors.

My INR is above 3.0 — should I be worried?

Whether an elevated INR is concerning depends on your target range and how high the value is. If your target is 2.0 to 3.0 and your INR is 3.1 to 3.9, this is mildly supratherapeutic — it may require a small dose reduction but is not typically dangerous without active bleeding. An INR of 4.0 to 5.0 represents significant supratherapeutic anticoagulation and usually requires holding one or two warfarin doses and reducing your weekly dose, along with same-day contact with your healthcare provider. An INR above 5.0 is considered critical and requires immediate provider contact, holding warfarin, and possible vitamin K administration. An INR above 9.0 is a medical emergency requiring urgent evaluation. If you are experiencing any bleeding symptoms — including unusual bruising, nosebleeds, blood in urine or stool, or severe headache — seek emergency care immediately regardless of your exact INR value.

Why does my INR fluctuate?

INR fluctuation is extremely common in warfarin patients and reflects the drug's sensitive interaction with many physiological variables. The most common causes include changes in vitamin K intake — eating more or fewer leafy green vegetables than usual can shift your INR significantly in either direction. Medications are another major source of variation: antibiotics (especially fluoroquinolones, macrolides, and metronidazole), antifungals, amiodarone, and NSAIDs tend to increase INR, while rifampin, some antiepileptics, and St. John's Wort decrease it. Illness, fever, diarrhea, alcohol use, and changes in liver function all affect how your body processes warfarin and vitamin K. Even small changes in diet consistency, sleep, or hydration can have measurable effects. This is why consistent habits — rather than dietary avoidance — are the foundation of stable anticoagulation management.

What does the ISI value mean and where do I find it?

The International Sensitivity Index (ISI) is a calibration number assigned by the manufacturer of the thromboplastin reagent used in your laboratory's PT test. It reflects how sensitive that particular reagent is to changes in clotting factor levels compared to the WHO International Reference Preparation. Modern recombinant thromboplastins typically have ISI values between 0.94 and 1.4 — the closer to 1.0, the more sensitive and consistent the reagent. Older reagents had ISI values up to 3.0, which produced much more variable INR results across different labs. You can usually find the ISI on your laboratory report alongside the PT result, or by calling your laboratory directly. If you cannot find it, a default value of 1.0 to 1.3 is reasonable for most modern laboratories, but confirming the exact value gives the most accurate INR calculation.

Can I use this INR calculator for liver disease or DOACs?

This calculator is specifically designed for monitoring vitamin K antagonist (VKA) therapy — primarily warfarin. It is not appropriate for interpreting PT/INR in liver disease. The INR formula was calibrated using plasmas from patients on oral anticoagulants, not liver disease patients, and liver disease affects both pro-coagulant and anti-coagulant factors simultaneously in ways the INR formula does not capture. In liver disease, INR overestimates bleeding risk and does not accurately reflect overall hemostatic competence. Direct oral anticoagulants (DOACs) such as rivaroxaban (Xarelto), apixaban (Eliquis), edoxaban (Savaysa), and dabigatran (Pradaxa) do not require INR monitoring at all — they are given at fixed doses and do not affect the INR in a therapeutically meaningful way. If you are on a DOAC, this calculator does not apply to your therapy.